No WHO Pandemic Preparedness Treaty Without Senate Approval Act
Summary
SB 1983, the “No WHO Pandemic Preparedness Treaty Without Senate Approval Act,” would require any convention, agreement, or other international instrument on pandemic prevention, preparedness, and response adopted by the World Health Assembly to be treated as a treaty subject to the U.S. Constitution’s Senate advice-and-consent process. In practical terms, the bill says that any such World Health Organization (WHO) pandemic agreement reached through the World Health Assembly’s negotiating process would need approval by two-thirds of the Senate before the United States could be bound by it.
The bill is built around findings criticizing WHO’s handling of COVID-19, emphasizing concerns about the organization’s independence, especially in relation to the People’s Republic of China, and citing prior U.S. withdrawal and retraction actions by the Trump and Biden administrations. It also references the scope of the proposed WHO pandemic agreement and the State Department’s criteria for deciding whether an international agreement should be treated as a treaty or executive agreement. The bill’s operative effect is to override any contrary treatment by deeming the agreement a treaty as a matter of U.S. law.
Impact
If enacted, the bill would affect how the United States can join or implement any WHO pandemic agreement arising from the World Health Assembly’s negotiating body. It would not itself create new public health rules, but it would impose a constitutional classification on such agreements, requiring Senate ratification and effectively preventing U.S. participation unless two-thirds of Senators consent. The measure would therefore constrain executive branch flexibility in international health negotiations and reinforce Senate control over pandemic-related international commitments.
Sentiment
The bill appears to have strong support among its Republican Senate sponsors and is framed as a defense of Senate prerogatives and national sovereignty. The text reflects skepticism toward WHO and concern about foreign influence, and the bill’s findings suggest a view that any pandemic agreement should face the highest level of Senate scrutiny. No committee transcript or vote record is provided, so there is no recorded bipartisan debate or formal vote sentiment in the available materials.
Contention
The main point of contention is whether a WHO pandemic agreement should be treated as a treaty requiring two-thirds Senate approval or as an executive agreement that the executive branch could enter without that threshold. Supporters argue the agreement is broad, potentially affects state laws, and implicates major national commitments, so Senate ratification is appropriate. Opponents, if any, would likely argue that the bill unnecessarily restricts U.S. diplomacy and could impede timely international cooperation on pandemic prevention and response. The bill also reflects broader political disagreement over WHO’s credibility, independence, and relationship with China.
Defending American Sovereignty in Global Pandemics ActThis bill prohibits the United States from becoming a party to a World Health Organization (WHO) agreement related to strengthening pandemic prevention, preparedness, and response except pursuant to a treaty made under Article II, Section 2, clause 2 of the U.S. Constitution (which requires that two-thirds of Senators present concur with the treaty).The bill also prohibits federal funding for WHO beginning on the effective date of such an agreement and ending on the date when the Senate ratifies the agreement.